Study: NCT01231503

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: BCG
Description: 1 dose, intradermal route, in shoulder at birth (=\< 7 days of age)

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: BCG
Description: 1 dose, intradermal route, in shoulder at birth (=\< 7 days of age)

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: BCG
Description: 1 dose, intradermal route, in shoulder at birth (=\< 7 days of age)

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: OPV
Description: 4 doses, orally, at birth (=\< 7 days of age) and at 6, 10 and 14 weeks of age

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: OPV
Description: 4 doses, orally, at birth (=\< 7 days of age) and at 6, 10 and 14 weeks of age

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: OPV
Description: 4 doses, orally, at birth (=\< 7 days of age) and at 6, 10 and 14 weeks of age

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: OPV
Description: 4 doses, orally, at birth (=\< 7 days of age) and at 6, 10 and 14 weeks of age

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: OPV
Description: 4 doses, orally, at birth (=\< 7 days of age) and at 6, 10 and 14 weeks of age

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: OPV
Description: 4 doses, orally, at birth (=\< 7 days of age) and at 6, 10 and 14 weeks of age

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: OPV
Description: 4 doses, orally, at birth (=\< 7 days of age) and at 6, 10 and 14 weeks of age

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: OPV
Description: 4 doses, orally, at birth (=\< 7 days of age) and at 6, 10 and 14 weeks of age

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Rouvax
Description: 1 dose, intramuscular (IM) route, in left antero-lateral thigh, at 9 months of age

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Rouvax
Description: 1 dose, intramuscular (IM) route, in left antero-lateral thigh, at 9 months of age

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Rouvax
Description: 1 dose, intramuscular (IM) route, in left antero-lateral thigh, at 9 months of age

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Rouvax
Description: 1 dose, intramuscular (IM) route, in left antero-lateral thigh, at 9 months of age

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Rouvax
Description: 1 dose, intramuscular (IM) route, in left antero-lateral thigh, at 9 months of age

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Rouvax
Description: 1 dose, intramuscular (IM) route, in left antero-lateral thigh, at 9 months of age

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Rouvax
Description: 1 dose, intramuscular (IM) route, in left antero-lateral thigh, at 9 months of age

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Rouvax
Description: 1 dose, intramuscular (IM) route, in left antero-lateral thigh, at 9 months of age